![Pfizer Eucrisa Ointment Has Been Approved By The US FDA For Use In Infants And Children Aged ≥3 Months! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd Pfizer Eucrisa Ointment Has Been Approved By The US FDA For Use In Infants And Children Aged ≥3 Months! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](https://www.hsppharma.com/Content/uploads/2020524038/202005071748185c438760cdaa4cda8ede332e31e70cab.png)
Pfizer Eucrisa Ointment Has Been Approved By The US FDA For Use In Infants And Children Aged ≥3 Months! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
![Positive Top-Line Results Seen in Study of Crisaborole for Mild to Moderate AD in Young Children - Practical Dermatology Positive Top-Line Results Seen in Study of Crisaborole for Mild to Moderate AD in Young Children - Practical Dermatology](https://core4-cms.imgix.net/tsj2QI0kgYUgdc090RbrLJugOcXDO9NoWHura0pE.png?auto=compress,format&)
Positive Top-Line Results Seen in Study of Crisaborole for Mild to Moderate AD in Young Children - Practical Dermatology
![Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis - JDDonline - Journal of Drugs in Dermatology Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_2967/table1.png)